There is actually a push here (ignoring mandated public funded trials) because the Minority populations are becoming large enough that if a diabetes drug that was better in black people existed there’s a massive underserved customer base. Follow the money...
I suppose I shouldn't be surprised, but I assumed that this sort of thing would have more traction outside of the U.S, which would then sort of (maybe) jump on the bandwagon.
